• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗击耐多药结核病国家行动计划

National action plan to combat multidrug-resistant tuberculosis.

出版信息

MMWR Recomm Rep. 1992 Jun 19;41(RR-11):5-48.

PMID:1640920
Abstract

At no time in recent history has tuberculosis (TB) been as great a concern as it is today. TB cases are on the increase, and the most serious aspect of the problem is the recent occurrence of outbreaks of multidrug-resistant (MDR) TB, which pose an urgent public health problem and require rapid intervention. A Task Force composed of representatives of many federal agencies has developed a National Action Plan for addressing this problem. The Task Force identified a number of objectives to be met if MDR-TB is to be successfully combatted. These objectives fall under the categories of a) surveillance and epidemiology--determining the magnitude and nature of the problem; b) laboratory diagnosis--improving the rapidity, sensitivity, and reliability of diagnostic methods for MDR-TB; c) patient management--effectively managing patients who have MDR-TB and preventing patients with drug-susceptible TB from developing drug-resistant disease; d) screening and preventive therapy--identifying persons who are infected with or at risk of developing MDR-TB and preventing them from developing clinically active TB; e) infection control--minimizing the risk of transmission of MDR-TB to patients, workers, and others in institutional settings; f) outbreak control; g) program evaluation--ensuring that TB programs are effective in managing patients and preventing MDR-TB; h) information dissemination/training and education; and i) research to provide new, more effective tools with which to combat MDR-TB. The Action Plan lays out a series of activities to be undertaken at the national level. For each category, the Plan presents statements of problems to be overcome, followed by a summary of the objective to be achieved and steps to be carried out. For each implementation step, responsibility is assigned to the appropriate organization and start-up dates are listed.

摘要

在近代史上,结核病从未像现在这样令人担忧。结核病病例正在增加,而问题最严重的方面是最近出现的耐多药结核病疫情,这构成了紧迫的公共卫生问题,需要迅速干预。一个由许多联邦机构代表组成的特别工作组制定了一项应对这一问题的国家行动计划。该特别工作组确定了若要成功抗击耐多药结核病需实现的若干目标。这些目标分为以下几类:a) 监测与流行病学——确定问题的严重程度和性质;b) 实验室诊断——提高耐多药结核病诊断方法的快速性、敏感性和可靠性;c) 患者管理——有效管理耐多药结核病患者,并防止药物敏感结核病患者发展为耐药疾病;d) 筛查与预防性治疗——识别感染耐多药结核病或有感染风险的人,并防止他们发展为临床活动性结核病;e) 感染控制——将耐多药结核病在机构环境中传播给患者、工作人员和其他人的风险降至最低;f) 疫情控制;g) 项目评估——确保结核病项目在管理患者和预防耐多药结核病方面有效;h) 信息传播/培训与教育;i) 研究,以提供新的、更有效的抗击耐多药结核病的工具。该行动计划列出了一系列将在国家层面开展的活动。对于每个类别,该计划都提出了需要克服的问题陈述,随后是要实现的目标和要采取的步骤的总结。对于每个实施步骤,都指定了适当的组织负责,并列出了启动日期。

相似文献

1
National action plan to combat multidrug-resistant tuberculosis.抗击耐多药结核病国家行动计划
MMWR Recomm Rep. 1992 Jun 19;41(RR-11):5-48.
2
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.抗击广泛耐药结核病计划:联邦结核病特别工作组的建议
MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.
3
The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis.耐多药结核病对结核病防控公共卫生努力构成的挑战。
Public Health Rep. 1992 Nov-Dec;107(6):616-25.
4
The epidemiology of multidrug-resistant tuberculosis in the United States.美国耐多药结核病的流行病学
Med Clin North Am. 1993 Nov;77(6):1391-409. doi: 10.1016/s0025-7125(16)30200-0.
5
HIV infection and multidrug-resistant tuberculosis: the perfect storm.艾滋病毒感染与耐多药结核病:完美风暴。
J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. doi: 10.1086/518665.
6
Meeting the challenge of multidrug-resistant tuberculosis: summary of a conference.应对耐多药结核病的挑战:会议总结
MMWR Recomm Rep. 1992 Jun 19;41(RR-11):51-7.
7
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
8
Management of persons exposed to multidrug-resistant tuberculosis.耐多药结核病接触者的管理
MMWR Recomm Rep. 1992 Jun 19;41(RR-11):61-71.
9
Multidrug resistant tuberculosis: trends and control.耐多药结核病:趋势与防控
Indian J Chest Dis Allied Sci. 2014 Oct-Dec;56(4):237-46.
10
Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis among Foreign-Born Persons. Centers for Disease Control and Prevention.外国出生人群结核病防控建议。外国出生人群结核病问题工作组报告。疾病控制与预防中心。
MMWR Recomm Rep. 1998 Sep 18;47(RR-16):1-29.

引用本文的文献

1
Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.加速结核病消除的潜伏性结核感染检测与治疗策略数学模型的政策影响
Public Health Rep. 2020 Jul/Aug;135(1_suppl):38S-43S. doi: 10.1177/0033354920912710.
2
Tuberculosis Regional Training and Medical Consultation Centers in the United States: Characteristics, outcomes, and quality of medical consultations, June 1, 2010 - May 31, 2014.美国结核病区域培训与医疗咨询中心:2010年6月1日至2014年5月31日的特征、成果及医疗咨询质量
J Clin Tuberc Other Mycobact Dis. 2019 Jul 2;17:100114. doi: 10.1016/j.jctube.2019.100114. eCollection 2019 Dec.
3
Epidemiology of Tuberculosis in the United States.
美国的结核病流行病学。
Clin Chest Med. 2019 Dec;40(4):693-702. doi: 10.1016/j.ccm.2019.07.001.
4
A child with complicated .一个患有复杂病症的孩子。
Int J Pediatr Adolesc Med. 2016 Mar;3(1):28-33. doi: 10.1016/j.ijpam.2015.11.003. Epub 2015 Dec 24.
5
Comparison of loop-mediated isothermal amplification assay and smear microscopy with culture for the diagnostic accuracy of tuberculosis.环介导等温扩增法与涂片显微镜检查及培养法在结核病诊断准确性方面的比较
BMC Infect Dis. 2017 Jan 17;17(1):79. doi: 10.1186/s12879-016-2140-8.
6
European policies on tuberculosis prevention in healthcare workers: Which role for BCG? A systematic review.欧洲医护人员结核病预防政策:卡介苗起何种作用?一项系统综述。
Hum Vaccin Immunother. 2016 Nov;12(11):2753-2764. doi: 10.1080/21645515.2016.1200776. Epub 2016 Jul 7.
7
Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.估算过去二十年美国结核病病例及其避免的经济成本。
Int J Tuberc Lung Dis. 2016 Jul;20(7):926-33. doi: 10.5588/ijtld.15.1001.
8
Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV setting.高 HIV 负担环境中卫生保健工作者对工作场所安全、感染控制和耐多药结核病的看法。
J Public Health Policy. 2013 Aug;34(3):388-402. doi: 10.1057/jphp.2013.20. Epub 2013 May 30.
9
Polymerase chain reaction in the diagnosis of tuberculosis.聚合酶链反应在结核病诊断中的应用
Indian J Clin Biochem. 2000 Aug;15(Suppl 1):200-16. doi: 10.1007/BF02867559.
10
Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough.二线耐药对美国结核病治疗结局的影响:耐多药结核病已经够糟糕了。
Int J Tuberc Lung Dis. 2012 Oct;16(10):1331-4. doi: 10.5588/ijtld.11.0812. Epub 2012 Aug 3.